Genelux Corporation (GNLX)
NASDAQ: GNLX · Real-Time Price · USD
2.870
-0.030 (-1.03%)
At close: Jun 26, 2026, 4:00 PM EDT
3.130
+0.260 (9.06%)
After-hours: Jun 26, 2026, 7:54 PM EDT
Genelux Employees
As of December 31, 2025, Genelux had 26 total employees, including 25 full-time and 1 part-time employees. The number of employees increased by 2 or 8.33% compared to the previous year.
Employees
26
Change (1Y)
2
Growth (1Y)
8.33%
Revenue / Employee
$308
Profits / Employee
-$1,291,577
Market Cap
127.45M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 26 | 2 | 8.33% |
| Dec 31, 2024 | 24 | 1 | 4.35% |
| Dec 31, 2023 | 23 | 8 | 53.33% |
| Dec 31, 2022 | 15 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| ADC Therapeutics | 193 |
| Fractyl Health | 100 |
| Agenus | 81 |
| Verrica Pharmaceuticals | 76 |
| Connect Biopharma Holdings | 64 |
| PepGen | 59 |
| Enlivex | 34 |
| Spero Therapeutics | 25 |
GNLX News
- 11 days ago - Genelux Transcript: AGM 2026 - Transcripts
- 7 weeks ago - Genelux reports Q1 EPS (20c), consensus (19c) - TheFly
- 7 weeks ago - Genelux Corporation Reports First Quarter Financial Results and Provides Business Updates - GlobeNewsWire
- 7 weeks ago - Genelux Quarterly report: Q1 2026 - Filings
- 7 weeks ago - Genelux Earnings release: Q1 2026 - Filings
- 7 weeks ago - Genelux Slides: Corporate presentation - Filings
- 2 months ago - Genelux Proxy statement: Proxy filing - Filings
- 2 months ago - Genelux Proxy statement: Proxy filing - Filings